Indigenous Dengue
Fever, Buenos Aires, Argentina
To the Editor: For 2 decades dengue has increased in the Americas, with epidemic peaks every 3 to 5 years (1) . The disease has reemerged in 3 South American countries bordering Argentina, namely, Bolivia, Brazil, and Paraguay.
Argentina had remained free from dengue for >80 years before the disease was reintroduced in 1998 (2) as a consequence of insuffi cient mosquito control and importation of cases from disease-epidemic areas. Since then, indigenous dengue circulation has only been reported in the northern provinces of the country, which are close to endemoepidemic countries. However, the principal dengue vector, the Aedes aegypti mosquito,, has spread southward to latitude 35°S near Buenos Aires (3) .
We describe what might be the southernmost indigenous case of dengue fever documented in South America; this case occurred in 2007, an epidemic peak year for the disease on this continent (1). The patient was a pneumonologist who worked parttime at Muñiz Hospital, a referral infectious diseases treatment center in the Buenos Aires Federal District. She also provided healthcare at an outpatient clinic in Lanus, her town of residence, a suburb 6 km south of the Federal District. Febrile illness started suddenly in February 2007, midsummer season in Argentina. On day 5 of illness, fever was replaced by a shortlived rash and itching followed by asthenia and nausea that persisted for 2 days. The patient had not traveled or been accidentally exposed to patients' blood during the previous weeks. She had never been vaccinated against yellow fever. Dengue fever was only suspected retrospectively.
Serologic results provided supportive evidence of a recent dengue infection i.e., presence of immunoglobulin M, as determined by antibody-capture enzyme immunoassay, and immunoglobulin G seroconversion by 90% plaque reduction neutralization test on Vero cells (4) . As shown in the Table, dengue virus serotype 3 was identifi ed, and antibody results were negative for 3 other fl aviviruses. Thus, this case fulfi ls Pan American Health Organization criteria for the diagnosis of dengue fever (5). Household contacts were seronegative.
For several years, conditions have been set for dengue virus circulation in Buenos Aires' urban and suburban areas because of the abundance of mosquitoes and disease in persons recently returning from neighboring countries. Risk for vector transmission is highest in the peripheral quarters of the city and towards late summer (6) . Besides, Buenos Aires, like other Latin American metropolitan areas, is undergoing demographic changes that convey further risk for mosquito-borne disease transmission, namely, accelerated population growth mainly caused by informal settlements, defi cient public health infrastructure and basic services, unregulated immigration from neighboring countries, and increased international mobility especially in or from neighboring countries (1) .
Only imported dengue cases have been previously documented in Buenos Aires (2). According to offi cial information, all 158 cases confi rmed by antibody conversion in Buenos Aires Federal District and Province during 2007 were also imported (7) . Of these, 50 occurred in the southern suburban district where our patient lives and works. In the summer of 2007, dengue infection was mainly introduced into the area by Paraguayan natives living in Buenos Aires who had recently visited their homeland. Dengue 3 serotype conversion was demonstrated in most of the cases investigated by plaque reduction neutralization assay, except for a few cases imported from Brazil, in which dengue 1 serotype was detected.
The opinions expressed by authors contributing to this journal do not necessarily refl ect the opinions of the Centers for Disease Control and Prevention or the institutions with which the authors are affi liated.
Most of the patients whose cases were diagnosed in Buenos Aires, including 5 who required hospitalization, were referred to Muñiz Hospital. Built a century ago, Muñiz Hospital comprises a number of independent pavilions surrounded by a spacious garden, where mosquitoes thrive, especially in summer. Thus, vectorborne infection in this case might have occurred either in Muñiz Hospital, in the Federal District, or in the southern city suburb, where the patient lives and works.
Until recently, dengue had not been suspected in patients with a fever living in the Buenos Aires area in the absence of a recent history of travel to an endemoepidemic area. Confi rmation of our case was evidence of local circulation of dengue virus. Thereafter, serum testing became recommended in Buenos Aires for acute febrile illness, among other dengue surveillance interventions in the area. More recently, epidemiologic surveillance of febrile illness has been strengthened countrywide upon the recent reporting of yellow fever cases in Argentina (8) .
No circulation of dengue virus was reported in Buenos Aires during the fi rst 10 epidemiologic weeks of 2008. However, vector control measures should be strengthened to minimize the risk of infective persons triggering an epidemic of dengue or other fl avivirus disease. 
Naegleria fowleri in Well Water
To the Editor: Naegleria fowleri, a protozoon found in hot springs and warm surface water, can cause primary amebic meningoencephalitis in humans. A survey of drinking water supply wells in Arizona determined that wells can be colonized and may be an unrecognized source of this organism that could present a human health risk.
N. fowleri is a free-living amebofl agellate found in warm bodies of water such as ponds, irrigation ditches, lakes, coastal waters, and hot springs and can cause primary amebic meningoencephalitis. Humans come into contact with N. fowleri by swimming or bathing, particularly in surface waters. The ameba enters the nasal passages, penetrates the nasopharyngeal mucosa, and migrates to the olfactory nerves, eventually invading the brain through the cribriform plate (1 
